BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma-Reference-Cited by-同舟云学术

BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma

Published:2016-12 Issue: Volume:97 Page:22-25
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Novak E.M.,Halley N.S.,Gimenez T.M.,Rangel-Santos A.,Azambuja A.M.P.,Brumatti M.,Pereira P.L.,Vince C.S.C.,Giorgi R.R.,Bendit I.,Cristofani L.M.,Odone-Filho V.

Funder

FAPESP

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma;Saulnier Sholler;Cancer Med,2015

2. Evaluation of bone marrow as a metastatic site of human neuroblastoma;Morandi;Ann N Y Acad Sci,2014

3. Neuroblastoma: biology, prognosis, and treatment;Park;Hematol Oncol Clin,2010

4. Mutational dynamics between primary and relapse neuroblastomas;Schramm;Nat Genet,2015

5. Neuroblastoma: biological insights into a clinical enigma;Brodeur;Nat Rev Cancer,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signature literature review reveals AHCY, DPYSL3, and NME1 as the most recurrent prognostic genes for neuroblastoma;BioData Mining;2023-03-04

2. GSEA–SDBE: A gene selection method for breast cancer classification based on GSEA and analyzing differences in performance metrics;PLOS ONE;2022-04-26

3. Screening and cellular validation of prognostic genes regulated by super enhancers in oral squamous cell carcinoma;Bioengineered;2021-12-20

4. Functional and Pathological Roles of AHCY;Frontiers in Cell and Developmental Biology;2021-03-31

5. Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma;Medical Science Monitor;2020-10-07